Shafer RW - Search Results

1

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.

Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW. Rhee SY, et al. Among authors: shafer rw. EBioMedicine. 2017 Apr;18:225-235. doi: 10.1016/j.ebiom.2017.03.024. Epub 2017 Mar 19. EBioMedicine. 2017. PMID: 28365230 Free PMC article.

2

Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years.

Winters MA, Shafer RW, Jellinger RA, Mamtora G, Gingeras T, Merigan TC. Winters MA, et al. Among authors: shafer rw. Antimicrob Agents Chemother. 1997 Apr;41(4):757-62. doi: 10.1128/AAC.41.4.757. Antimicrob Agents Chemother. 1997. PMID: 9087484 Free PMC article. Clinical Trial.

3

Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs.

Kantor R, Machekano R, Gonzales MJ, Dupnik K, Schapiro JM, Shafer RW. Kantor R, et al. Among authors: shafer rw. Nucleic Acids Res. 2001 Jan 1;29(1):296-9. doi: 10.1093/nar/29.1.296. Nucleic Acids Res. 2001. PMID: 11125118 Free PMC article.

4

Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy.

Shulman N, Zolopa AR, Passaro D, Shafer RW, Huang W, Katzenstein D, Israelski DM, Hellmann N, Petropoulos C, Whitcomb J. Shulman N, et al. Among authors: shafer rw. AIDS. 2001 Jun 15;15(9):1125-32. doi: 10.1097/00002030-200106150-00007. AIDS. 2001. PMID: 11416714

5

Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy.

Kantor R, Fessel WJ, Zolopa AR, Israelski D, Shulman N, Montoya JG, Harbour M, Schapiro JM, Shafer RW. Kantor R, et al. Among authors: shafer rw. Antimicrob Agents Chemother. 2002 Apr;46(4):1086-92. doi: 10.1128/AAC.46.4.1086-1092.2002. Antimicrob Agents Chemother. 2002. PMID: 11897594 Free PMC article.

6

HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.

Kantor R, Zijenah LS, Shafer RW, Mutetwa S, Johnston E, Lloyd R, von Lieven A, Israelski D, Katzenstein DA. Kantor R, et al. Among authors: shafer rw. AIDS Res Hum Retroviruses. 2002 Dec 10;18(18):1407-13. doi: 10.1089/088922202320935483. AIDS Res Hum Retroviruses. 2002. PMID: 12512512 Free PMC article.

7

Human immunodeficiency virus reverse transcriptase and protease sequence database.

Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Ravela J, Shafer RW. Rhee SY, et al. Among authors: shafer rw. Nucleic Acids Res. 2003 Jan 1;31(1):298-303. doi: 10.1093/nar/gkg100. Nucleic Acids Res. 2003. PMID: 12520007 Free PMC article.

8

Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors.

Gonzales MJ, Wu TD, Taylor J, Belitskaya I, Kantor R, Israelski D, Chou S, Zolopa AR, Fessel WJ, Shafer RW. Gonzales MJ, et al. Among authors: shafer rw. AIDS. 2003 Apr 11;17(6):791-9. doi: 10.1097/00002030-200304110-00003. AIDS. 2003. PMID: 12660525 Free PMC article.

9

Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.

Wu TD, Schiffer CA, Gonzales MJ, Taylor J, Kantor R, Chou S, Israelski D, Zolopa AR, Fessel WJ, Shafer RW. Wu TD, et al. Among authors: shafer rw. J Virol. 2003 Apr;77(8):4836-47. doi: 10.1128/jvi.77.8.4836-4847.2003. J Virol. 2003. PMID: 12663790 Free PMC article.

10

HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms.

Ravela J, Betts BJ, Brun-Vézinet F, Vandamme AM, Descamps D, van Laethem K, Smith K, Schapiro JM, Winslow DL, Reid C, Shafer RW. Ravela J, et al. Among authors: shafer rw. J Acquir Immune Defic Syndr. 2003 May 1;33(1):8-14. doi: 10.1097/00126334-200305010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 12792349 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters